Basel, Switzerland

Enrique Vidal Ocabo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Roche Molecular Systems, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrique Vidal Ocabo. Retrieved from https://idiyas.com/inventor/enrique-vidal-ocabo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enrique Vidal Ocabo and His Patent Work.

Introduction

Enrique Vidal Ocabo is an inventor based in Basel, Switzerland. His recorded patent work includes an interface concept for reconstructing and aggregating patient pathways.

Latest Patents

Vidal Ocabo is associated with one patent: “Display screen or portion thereof with graphical user interface for patient pathway reconstruction and aggregation.” The patent describes a graphical user interface designed to support the reconstruction and aggregation of patient pathways. His record lists 1 patent.

Career Highlights

Vidal Ocabo is associated with Roche Molecular Systems, Inc. His listed patent connects digital interface design with the organization and presentation of patient pathway information.

Collaborations

His listed coworkers include Fernando Garcia-Alcalde and Marie Elisabeth Stobbe Kammersgaard.

Conclusion

Enrique Vidal Ocabo’s recorded invention focuses on a graphical interface for patient pathway reconstruction and aggregation, reflecting his association with Roche Molecular Systems, Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…